RARE CANCER
Clinical trials for RARE CANCER explained in plain language.
Never miss a new study
Get alerted when new RARE CANCER trials appear
Sign up with your email to follow new studies for RARE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
10,000 cancer patients join ontario Gene-Mapping effort to personalize care
Knowledge-focused Recruiting nowThis study aims to collect and analyze tumor samples from 10,000 adults with advanced solid cancers (like breast, lung, or colon cancer) to create a province-wide gene database. The goal is to help doctors identify which targeted drugs or clinical trials might work best for each …
Matched conditions: RARE CANCER
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Massive cancer DNA hunt aims to stop relapse before it starts
Knowledge-focused Recruiting nowThis study enrolls 7,000 people with various cancers who have had or will have treatment aimed at a cure. Researchers collect blood, tissue, urine, and saliva samples over time to look for tiny bits of cancer DNA left behind. The goal is to find any remaining cancer as early as p…
Matched conditions: RARE CANCER
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Gene-Tailored therapy could be Game-Changer for rare cancer patients
Knowledge-focused Recruiting nowThis study tests whether using a patient's unique genetic information to choose their cancer treatment leads to better results than standard care. About 946 adults with advanced rare cancers will be randomly assigned to either immediate personalized treatment or standard treatmen…
Matched conditions: RARE CANCER
Sponsor: German Cancer Research Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Rare cancer patients wanted for landmark registry study
Knowledge-focused Recruiting nowThis study is creating a registry of adults with rare cancers in Korea to see how many take part in clinical trials. Researchers will track participation rates over time. No new treatments or drugs are being tested.
Matched conditions: RARE CANCER
Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC